BACKGROUND O
: O
Ischemic O
heart O
disease O
is O
the O
primary O
cause O
of O
morbidity O
and O
mortality O
among O
diabetics _RARE_
, O
especially O
those O
who O
became O
ill _RARE_
at O
a O
young O
age O
. O

More O
importantly _RARE_
, O
this O
fusion I-GENE
converted O
a O
less O
effective O
vaccine O
into O
one O
with O
significant O
potency O
against O
established O
E7 I-GENE
- I-GENE
expressing O
metastatic O
tumors O
. O

Reverse _RARE_
transcription I-GENE
- I-GENE
PCR O
analysis O
of O
mRNA I-GENE
from O
patients O
shows O
that O
each O
of O
these O
five O
mutations O
results O
in O
aberrant O
splicing O
. O

Using O
the O
postural _RARE_
and O
force O
data O
as O
input O
to O
a O
3 I-GENE
- I-GENE
D I-GENE
biomechanical _RARE_
model O
, O
the O
lumbosacral _RARE_
spinal O
compression O
was O
calculated O
. O

Sequence O
analysis O
revealed O
significant O
differences O
between O
the O
5 I-GENE
' O
region I-GENE
of O
the O
beta I-GENE
subunit I-GENE
gene I-GENE
and O
the O
corresponding O
regions O
of O
the O
homologous I-GENE
GlyR _RARE_
alpha I-GENE
subunit I-GENE
genes I-GENE
; O
it O
also O
identified O
a O
novel O
exon O
( O
exon O
0 O
) O
that O
encodes O
most O
of O
the O
5 I-GENE
'- I-GENE
untranslated O
portion O
of O
the O
GlyR _RARE_
beta I-GENE
mRNA I-GENE
. O

Therefore O
, O
we O
suggested O
that O
both O
proteins I-GENE
might O
belong O
to O
the O
PLTP _RARE_
family I-GENE
. O

Influence O
of O
compression O
therapy O
on O
symptoms O
following O
soft O
tissue I-GENE
injury O
from O
maximal O
eccentric _RARE_
exercise O
. O

STAT5A _RARE_
mutations O
in O
the O
Src I-GENE
homology I-GENE
2 I-GENE
( O
SH2 I-GENE
) O
and O
SH3 I-GENE
domains I-GENE
did O
not O
alter O
the O
BTK _RARE_
- I-GENE
mediated O
tyrosine I-GENE
phosphorylation O
. O

In O
the O
present O
work O
, O
the O
complete O
genome O
sequences I-GENE
of O
Pyrococcus _RARE_
horikoshii _RARE_
and O
Pyrococcus _RARE_
abyssi _RARE_
, O
two O
species O
in O
a O
genus O
of O
hyperthermophilic _RARE_
archaeon _RARE_
( O
archaebacterium _RARE_
), O
were O
compared O
to O
detect O
large O
genome O
polymorphisms _RARE_
linked O
with O
restriction O
- I-GENE
modification O
gene I-GENE
homologs I-GENE
. O

In O
addition O
, O
these O
patients O
show O
both O
quantitative O
and O
qualitative O
differences O
in O
their O
infectious O
microbiological _RARE_
spectrum O
, O
mainly O
in O
clean _RARE_
- I-GENE
contaminated O
, O
contaminated O
and O
dirty _RARE_
surgical O
procedures O
. O

Here O
we O
show O
that O
PKC I-GENE
and O
p44 I-GENE
/ I-GENE
p42MAPK _RARE_
signalings _RARE_
are O
required O
for O
the O
HBx _RARE_
- I-GENE
induced O
Sp1 I-GENE
- I-GENE
mediated O
IGF I-GENE
- I-GENE
II I-GENE
P4 _RARE_
transcriptional O
activity O
since O
( O
i O
) O
PKC I-GENE
activation O
by O
PMA O
or O
PKC I-GENE
expression O
vector O
increases O
Sp1 I-GENE
phosphorylation O
and O
P4 _RARE_
activity O
in O
HBx _RARE_
- I-GENE
transfected O
HepG2 O
cells O
; O
( O
ii O
) O
PKC I-GENE
inhibition O
by O
PKC I-GENE
inhibitor I-GENE
Go6976 _RARE_
reduces O
Sp1 I-GENE
phosphorylation O
, O
P4 _RARE_
activity O
, O
and O
IGF I-GENE
- I-GENE
II I-GENE
mRNA I-GENE
in O
HBx _RARE_
- I-GENE
transfected O
HepG2 O
cells O
; O
and O
( O
iii O
) O
the O
inhibition O
of O
MEK I-GENE
activation O
by O
U0126 _RARE_
reduces O
Sp1 I-GENE
phosphorylation O
, O
P4 _RARE_
activity O
and O
IGF I-GENE
- I-GENE
II I-GENE
mRNA I-GENE
in O
HBx _RARE_
- I-GENE
transfected O
HepG2 O
cells O
. O

We O
show O
that O
p73 _RARE_
can O
transcriptionally O
inhibit O
a O
number O
of O
cellular O
and O
viral I-GENE
promoters I-GENE
. O

Similarly O
, O
curcumin _RARE_
( O
diferuloylmethane _RARE_
), O
an O
anti I-GENE
- I-GENE
inflammatory O
agent O
, O
suppressed O
OSM _RARE_
- I-GENE
stimulated O
STAT1 I-GENE
phosphorylation O
, O
DNA I-GENE
- I-GENE
binding I-GENE
activity O
of O
STAT1 I-GENE
, O
and O
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
activation O
without O
affecting O
JAK1 _RARE_
, O
JAK2 _RARE_
, O
JAK3 _RARE_
, O
ERK1 I-GENE
/ I-GENE
2 I-GENE
, O
and O
p38 I-GENE
phosphorylation O
. O

The O
effects O
of O
the O
transfected O
receptors I-GENE
were O
associated I-GENE
with O
antagonism _RARE_
of O
activator I-GENE
protein I-GENE
1 I-GENE
( O
AP I-GENE
- I-GENE
1 I-GENE
) O
activity O
. O

